Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Key outcomes of all-cause mortality and portal hypertension complications are improved with SGLT2inhibitors, new research ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Researchers from the Karolinska Institutet in Sweden have found a potential new treatment for non-alcoholic fatty liver ...

Global research into the gut microbiome has exploded over the past decade, with most of the spotlight shining on the complex, ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

Metabolic liver disease might not get as much attention as heart disease or diabetes, but it affects around one in four ...

Ozempic, a diabetes drug, shows promise for liver disease. Research indicates it can reverse non-alcoholic steatohepatitis. A ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Malayalam film and television actor Vishnu Prasad passed away at the age of 49 in Kochi while he was undergoing treatment for ...

Results showed that 62.9% of patients on Ozempic saw a reduction in liver inflammation, compared to 34.3% on placebo.